Microbial Keratitis in East Africa: Why are the Outcomes so Poor?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
PURPOSE: Microbial keratitis (MK) is a major cause of blindness in Africa. This study reports the epidemiology, causative organism, management and outcome of MK in people admitted to a large referral hospital in Northern Tanzania, and explores why the outcomes are so poor for this condition. METHODS: A retrospective review of all admissions for MK during a 27-month period. Information was collected on: demographics, history, examination, microbiology, treatment and outcome. RESULTS: A total of 170 patients with MK were identified. Presentation was often delayed (median 14 days), and more delayed if another health facility was visited first (median 21 days). Appropriate intensive antibiotic treatment was prescribed in 19% before admission. Lesions were often severe (41% >5mm). Filamentary fungi were detected in 25% of all specimens (51% of specimens with a positive result). At discharge, 66% of affected eyes had a visual acuity of less than 6/60. Perforations developed in 30% and evisceration was necessary in 8%. Perforation was associated with large lesions and visiting another health facility. HIV infection was diagnosed in 16% of individuals tested, which is approximately twice the prevalence found in the wider population. CONCLUSIONS: Microbial keratitis is a significant clinical problem in this region, which generally has a very poor outcome. Delayed presentation is a critical issue. Fungal keratitis is a prominent cause and there is an indication that HIV may increase susceptibility. Prompt recognition and appropriate treatment in primary/secondary health facilities and rapid referral when needed may reduce the burden of blindness from this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upadhyay, M. P., Karmacharya, P. C. D., Koirala, S., Tuladhar, N. R., Bryan, L. E., Smolin, G., & Whitcher, J. P. (1991) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76903-x · Cited by 329 · cited 1×
“Ninety-two people had received one or more identifiable treatments prior to admission: chloramphenicol (49), ciprofloxacin (18), tetracycline (9), gentamicin (15), povidone Iodine (12) and econazole (4).”
BackgroundIncidence of Ulcerative Keratitis in a Defined Population From 1950 Through 1988
Erie, J. C. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090120087027 · Cited by 268
Incidence of corneal ulceration in Madurai district, South India
Gonzales, C. A., Srinivasan, M., Whitcher, J. P., & Smolin, G. (1996) · Ophthalmic Epidemiology · doi:10.3109/09286589609080122 · Cited by 202 · cited 2×
“Ninety-two people had received one or more identifiable treatments prior to admission: chloramphenicol (49), ciprofloxacin (18), tetracycline (9), gentamicin (15), povidone Iodine (12) and econazole (4).”
Background
Cited by
Ung, L., Bispo, P. J. M., Shanbhag, S. S., Gilmore, M. S., & Chodosh, J. (2019) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2018.12.003 · Cited by 546
The global incidence and diagnosis of fungal keratitis
Brown, L., Leck, A. K., Gichangi, M., Burton, M. J., & Denning, D. W. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30448-5 · Cited by 495
Self-citationParkes‐Ratanshi, R., Achan, B., Kwizera, R., Kambugu, A., Meya, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12387 · Cited by 49
Burden of serious fungal infections in Tanzania
Faini, D., Maokola, W., Furrer, H., Hatz, C., Battegay, M., Tanner, M., Denning, D. W., & Letang, E. (2015) · Mycoses · doi:10.1111/myc.12390 · Cited by 42
Estimated burden of fungal infections in Kenya
Guto, J. A., Bii, C. C., & Denning, D. W. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7614 · Cited by 36
Metadata
- Authors
- Burton, M. J., Pithuwa, J., Okello, E., Afwamba, I., Onyango, J. J., Oates, F., Chevallier, C., & Hall, A. B.
- Venue
- Ophthalmic Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2011-07-22
- Volume
- 18
- Issue
- 4
- Pages
- 158-163
- ISSN
- 0928-6586 (ISSN-L)
- 1744-5086
- OpenAlex
- W2156995984
- Cited by
- 104
- References
- 3
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.